DROR: Dror Ortho-Design, Inc. Stock

by  •  • Comments Off on DROR: Dror Ortho-Design, Inc. Stock

SIC 3843 – Dental Equipment and Supplies

Valuation
Market Cap ($M) 3.16
Enterprise Value ($M) 2.61
Book Value ($M) -0.37
Book Value / Share -0.00
Price / Book -8.58
NCAV ($M) -0.39
NCAV / Share -0.00
Price / NCAV -8.05

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.16
Return on Equity (ROE) -2.42

Liquidity (mrq)
Quick Ratio 0.70
Current Ratio 0.70

Balance Sheet (mrq) ($M)
Current Assets 0.64
Assets 0.66
Liabilities 1.03
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -5.22
Net Income -5.78
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.74
Cash from Investing -0.03
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-25 13G/A Hirschman Orin

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-19 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPO
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU
2024-05-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P

(click for more detail)

Similar Companies
BRSYF – BrainsWay Ltd. BTCY – Biotricity, Inc.
CLHLF – COLTENE Holding AG DYNT – Dynatronics Corporation
ECIA – Encision Inc.


Financial data and stock pages provided by
Fintel.io